Felbamate in Lennox-Gastaut Syndrome
The Felbamate Study Group report results in 73 patients ages 4 to 36 years with the Lennox-Gastaut syndrome, using a double-blind, placebo- controlled, add-on trial design.
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Pediatric Neurology Briefs Publishers,
1993-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|